Integrated Filing- Financial

IIIDUIIRIEX LID Head,Otfice : 301, Aura Biplex, Premium Retail Premise$, 7, S.V. Fload, Borivali (West), lVlumbai - 400092. E-mail r compliance@sudarshanpharma,com . tlleLsite: www.sudarshanpharma,com 3oar$Lins: +91-22-42221111 143831111 142221116 {10S line)o Qlp : 151496MH2008P1C184997 sPr L/cs/sE/2026-2027 /7 1 Date: 29th October 2026 ijiii i,:,, :1 - The Listing Department The Listing Department BSE Limited National Stock Exchange of lndia Limited Phiroze Jeejeebhoy Towers, Exchange Plaza, C-1,, Block G, Dalal Street, Bandra Kurla Complex, Bandra (E), Mumbai - 400-001 Mumbai - 400 051 BSE Scrip Code: 543828 NSE Trading Symbol: SUDARSHAN Ref: Regulation 33 of SEB! (Listing Obligations And Disclosure Requirements) Regutations , ZOL1 Sub: Outcome of the Meeting of Board of Directors of the Company held on Thursday, 29th October,2026 Dear Sir / Madam, Pursuant to Regulation 33 of the SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015, we are submitting herewith Unaudited Standalone & Consolidated Financial Results for the quarter and half year ended on 30th September, 2026 as approved by the Board of Directors of the Company along-with Auditors' Limited Review Report at its meeting held today. The meeting of the Board of Directors commenced at 7.00 pm and concluded at 10.00 pm. We request you to kindly take the above information on record. Thanks & Regards, Yours faithfully, For Sudarshan Pharma lndustries Limited Compiny Secretary & Compliance Officer Regd. Off. : 301, Aura Biplex, Above Kalyan Jewellers, $.V, Rcad, Borivali (West), lvlumbai - 400092 $I}I}AH$H*il FHfiTIIII* IItI$t'$Yffi E$ LYil} Fl**rt0flretl .''. i,'r: ' :: '"'.": i E"nraii . j.'r.":::.'r:"r,:,1 s -,:,1'!i'r i':i,l .:I.':.: r:jrlr' WebSile:;,,i.:,t..ri::'::l,i1l:r'-1:ia':l.i;'::'i I--:: ; ;-'^r -i- -:;-': :i:--.-'':::--": - l l i.r: : ;5 -r-':i :l :;-:: : " :-*'L:-:': ;i' S'I-,{TEIvIE}IT {fF ST,tu\DALOi.iE L}iALiDITE* FIN.{NCL4.L RESI,iLT-c FoR THE QUAI{TER AliD SIX }IONTIIS ENTED 30TH SEPTHN,IBER, 2026 r)i Qtrarter ended Year Endeti Sr. No. Particulars Sept 30, 2026 Sepr 30. 2025 .l nne 30" 2025 Sept 3Q 2026 Sepl 3Q 2025 lvlarch 31, 2026 Unaudited Unaridited tli: Lnaudited Unauriited Unaudited Audited Incomq Rel.errre {rm cperaiiols ?c.5s1.8r'r r6.70S.63 16.S6.03 37,G67.83 3rJ,931.74 66,7,19.85 Other ilr:cme 7*+.17 ?89.X 135.38 1i9.;5 350.ir9 840.44 A Total in.:orne 2*,686.17 16,90?.E6 15.7{11.4t 37.3.87.54 57.59A.29 Expense: Cost ol material coremed 157.58 65.93 '107.25 264.83 2L)7.68 Purchase of stock-in-trade 19J75.06 77,776.01 15.879.80 35,051.87 31,061.58 65,599.01 Chmgs in invmloris o{ {inishtd gwds, stock-ia- {?-1&1-:9i €,157,10) {1,868.1s} 13,97t.111 {3,369.58) 17,063.44) trade and wods-ifl-1:rc9:s Emplcyee benelit expenre t78.85 139.95 172.8? 351.74 ?66.20 678.97 Fimrce cost 1,*:.I.{;: {€.88 s1c.4d 1,854.G8 1,178.18 2,529.74 Deprer-iation md mo*istia11 exlErc 126.46 sr].68 1?9.1? 255.58 '159.66 340.65 Otherexpeffi 1,m4.53 tr]5nt 647.29 1d71.8? u7.6? 2,i1,OO.A7 B Total expenses 19.592.82 76,4?7.35 13,&87.66 35_41tO.48 30.280_53 64.723.48 Prcfi{(Loss) before exceptional items atd ts for '1,093.35 482.5.I 813.75 1,907.10 1,001,90 2,E66.E2 the period (A-B) l--rr epiional llenr< Profit lrefore lax 'l -{,s3.35 .18?.51 813.75 1,N7;10 1 _001_39 2_966"8: E Taa?ene {a) Cu[ent tax 3oll.?f 1 16.61 217.95 578.17 233.b5 683.92 (t) ilpferpd tax i.1r.l8l {;-.}.161 18.38) ia.7b) 145.O8) (15.27\ F Total tax expense iD-Ei 31 3.84 1?47 209.57 523-41 't 88.57 666.65 C Nel orofit for the rerioril vear iD-Fii 779-51 4140.03 60413 1_38i_69 sl 3.33 2"198.1 6 H Other comprehenaive income, aet of iacooe tax i) itffi Lhdt will not be rq l*ureci to ;,rotrt or lm *.51 i1.16i 0.51 1.$2 (2.:32) 2.M ii) irco&e tffi relaring to iteEs il]at will r*tlre {0.13} B"?9 {0.r3} (0.26) 0.5!l (0.5r ) reclmsilied fo r:rofif or lms 1-otal other comprehensive income, net of incorne 0.3s (0.87i 0.38 0.76 11.74) 1.53 I Total complehercive income fsr fhe perisdl year w9"89 439.16 604.56 1,384.45 al1 <o z;199.69 Paid up equita share cpital : $ace valne iNR 1 ?F,14.?r 2J0{:.59 2,.1!.16.5!r ?,544.71 2,406.59 2,406.59 each) 1 Other erraity 72.863.92 K Earninga pershare {in RsJ Frcm Cortiruing operation* a Basic EPS: {in INR) s.3? t].1.q 0.25 0.16 0.34 0.91 Diluted EIi9 : {in INR) {Re{s rere 11) a32 a).18 0.?5 0.56 0.33 0.90 xltt Debt Equity Ratio ?.93 ?.03 1.84 xlv Debt Service C*varage,Rati* '1.6& 1.65 1.66 1.51 XV lntercst CoYffa*e R.alio ?.06 2.{t! ?.03 2.75 For Pharara Iadrsfies Llnited Hemal Mehta lu{l-ii,t'*P'l (i\'Ianaging DIN:0221112t Place : Mumbai Date 129-1fr-2t26 Resd. Gff.: 301, Aura Biplex. Abcr;e Kalvan .Ier.ve[1ers, S V Road, Bogivali (West),li1lumbai 4{}00q2 1 N T t bl erho e eete i n rFs r p i ent ro sa ep n pS ec act i raa etill dv d e sa t il nao mt n e aee m ce ce t oiF n . rgi t dn s s aa nn h h cac d esi la d wbl e o ir te ne hn s o u tr c hl et ets v o : i Cbe ew omre d p2 a9a n,2. ied 0 s2 r 6e {. ic T no h dm e ia m nse t an Atd cae ctod {}r Iy rb n y a ti n*M gd e itm sa tr ab s ne dr hs aa rvo cef l) t ish Rse u* iA e edu s ,r al 2i nt 0 1C u 5no m (m Inom ddi it f At ie e Se c ) i a prn re ed p s o ca r rp t ib p o er n do v th *e ned ds eb e y rr e st sh eue cl t tB s ioo ' na T r h 1c il 3s 3o sf o tD a f t ti er he m ec eto nr t s h a at s Companies Act,2013 and rtfes amended from time to time' 2 T h rerh d pe i oa C r. to aTm bh le ep a C sn eoy gn mris p e ae nnn ty g aa 1isg rd e e d tr. h ri gn . a rgm "a gda . n ri *nu r f .a t th -c e *tu i sbr euin s g i dn ieo ss cf s loA sop uf ! rs ei] eo rcb eiw a qlo urtr iy rk e mcm h ea e nn m tu i of ca fa c ll Nt su o Dr nin l Ayg ^ S ai n n 1 0dP 8 h th oa e nrm r e oa f poc ere e ru a, t ti itc nha gels r e s eit is ge mm o ens nlya t n io sd n netr o a r ted ape pors pr t lai in cb a lc e bh lee s em tg oic m ia tel 's n t'a n Td h es ro el v ie sn .t os in s The previous periorls, fig,res have been re-gro*ped 1 re-arrarg,ed 1 re-casted wherever necessary to make it c*mparable with the current period. 4 T t whh eee b ' sEs it tBa est Iu (t oLo fi r sy Bt SinA Eg u L d o imbit io l tig ers <a lt h io aa n *v s de c Nao n an d td i .u D nc i aste lc r lo sl ts oa u crl ki e. , . Ei Rte xer cl q h. aur *e ir gv e ei me . oe*, f* to Is nf ) d t Ri ir ae e g La u ib ,l ro a itv t eie o < n lm s a,e lon 2 n0ti 1 go 5 -. w.e Td ith h q e u tR ha eer t pe reor sl rv ui loa tsfn td ah neh d a s l itf sa y t aue lt sa o or r yr ae vas au u ill d ats i bt o la ers s o r we ni l iu tl hli b ere e Cd oub mpy l po R aa ne d yg e '; sdr l a o wti . eo bn th s e i3 te3 of www.sudarshanPharma.ccm' 5 w M pr. a oe i v. nf i. B i2 ooT nat sh r do o hBb eSe E sr L2 ci0 um2 ri6 i tt i, ee t srh l e aa nc no dd r En lisp xt ca in hn g ay o gs a eu c t Bc h oe e as ms rdfu a l oil ny Lbc ro do a in arr d p (l soe Eft e BNd Ia t t rh io ee n r a ur l lr ai ,g t{ it or ra nxt k si o aElo nx df c h i tt a hs n e g rq e u lo eit i vy ln s n.{h ti a u rr e L ls i smf ,r o i ctm e ir4- ct h ue i ln rs a sM c acE no drP d a gla n ut c if do e er m w lini t eo h sf 'B thS eE a L pi pm lii cte abd l eto the 6 D u clnu oi sr ti . un rTg eh eQ is u d ea e xct pe i esr cil oy ten a d w id ta o s H h ta eal lkf p e y tne h a ear f ctee orn m d e pe vd aa nl3 u y0 a t { rh i an s tg ie o p t nht ae e lm iz*rb ere itr f, is x2 eo0 p2 i e6 a., nr t a dh t e ir c g pC eo p rem ar tfp io ra grr, y , ca ond sce tsec ,i d a ne * f<d n1 i mt io ts izd c eis o c n fo *k rn i tbt hin u eu t rie o l n oit s s st o em st ,a h e an ,u 'C dfa a ec m ntu apr bain l* eg y ' mso ap fi nne aar ga n et ci mo iai el ls n r ta e t s t outh l fe t os c'P uTa shl g e ith sar resources olr mote sustainable and profitable operations ? v a C B Ri wd uih h pae u a er r.r el i ile ll s aait nt ll l e r C Jiir nt i s nhd eD ua f a nt u Ce iv b l rd .o oaa u rl3 i e,r1 h sUs a a t En vr nJ ei it gu o e b hl uy d e tn, e eAc e2 *e n0 r ad o2 -L[4 r: ad b t E keyo hrm et sB h i dS re [Showing first 8,000 characters — download PDF for full document]